4.64
price up icon3.80%   0.17
after-market Handel nachbörslich: 4.64
loading

Evoke Pharma Inc Aktie (EVOK) Neueste Nachrichten

pulisher
Dec 31, 2024

Head to Head Contrast: Northwest Biotherapeutics (OTCMKTS:NWBO) vs. Evoke Pharma (NASDAQ:EVOK) - Defense World

Dec 31, 2024
pulisher
Dec 30, 2024

Thinking about buying stock in Agile Therapeutics, Evoke Pharma, Warner Bros Discovery, Nkarta, or Sky Harbour? - Marketscreener.com

Dec 30, 2024
pulisher
Dec 30, 2024

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Defense World

Dec 30, 2024
pulisher
Dec 23, 2024

Financial Survey: Evoke Pharma (NASDAQ:EVOK) and Geron (NASDAQ:GERN) - Defense World

Dec 23, 2024
pulisher
Dec 22, 2024

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Dec 22, 2024
pulisher
Dec 19, 2024

Siga Technologies (SIGA) Stock Surges Over 5% Amid Market Activi - GuruFocus.com

Dec 19, 2024
pulisher
Dec 19, 2024

Diabetic Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharmaceuticals, Ironwood Pharma, Takeda - The Globe and Mail

Dec 19, 2024
pulisher
Dec 19, 2024

Adeia Enters into Multi-Year IP License Agreement with Canon - The Manila Times

Dec 19, 2024
pulisher
Dec 19, 2024

Diabetic Gastroparesis Pipeline Trends 2024: Clinical Trials, - openPR

Dec 19, 2024
pulisher
Dec 19, 2024

Evoke Pharma Highlights GIMOTI as a Leading Solution for Gastroparesis Treatment as Domperidone Supply Ends - GlobeNewswire

Dec 19, 2024
pulisher
Dec 10, 2024

Gastroparesis Treatment Market Generated Opportunities, - openPR

Dec 10, 2024
pulisher
Dec 06, 2024

Target Corp (TGT-N) QuotePress Release - The Globe and Mail

Dec 06, 2024
pulisher
Dec 06, 2024

Evoke Pharma (NASDAQ:EVOK) Now Covered by StockNews.com - Defense World

Dec 06, 2024
pulisher
Dec 05, 2024

EVOK (Evoke Pharma) 5-Day RSI : 40.08 (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 05, 2024

EVOK (Evoke Pharma) Price-to-Operating-Cash-Flow : (As of Dec. 05, 2024) - GuruFocus.com

Dec 05, 2024
pulisher
Dec 03, 2024

Gray Television (GTN-N) QuotePress Release - The Globe and Mail

Dec 03, 2024
pulisher
Dec 03, 2024

Mercadolibre Inc (MELI-Q) QuotePress Release - The Globe and Mail

Dec 03, 2024
pulisher
Dec 03, 2024

Paramount Global Cl B (PARA-Q) QuotePress Release - The Globe and Mail

Dec 03, 2024
pulisher
Dec 03, 2024

Comfort Systems USA (FIX-N) QuotePress Release - The Globe and Mail

Dec 03, 2024
pulisher
Dec 03, 2024

Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting GIMOTI® - GlobeNewswire

Dec 03, 2024
pulisher
Nov 29, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Nov 29, 2024
pulisher
Nov 28, 2024

TSX Utilities Capped Index (TTUT) QuotePress Release - The Globe and Mail

Nov 28, 2024
pulisher
Nov 28, 2024

EVOK (Evoke Pharma) 5-Day RSI : 34.66 (As of Nov. 28, 2024) - GuruFocus.com

Nov 28, 2024
pulisher
Nov 27, 2024

Dell Technologies Inc (DELL-N) QuotePress Release - The Globe and Mail

Nov 27, 2024
pulisher
Nov 26, 2024

Gastroparesis Drugs Market to Grow by USD 1.42 Billion (2024-2028), Diabetes Burden Boosts Growth, AI Impact on Market TrendsTechnavio - The Malaysian Reserve

Nov 26, 2024
pulisher
Nov 23, 2024

First Solar Inc (FSLR-Q) QuotePress Release - The Globe and Mail

Nov 23, 2024
pulisher
Nov 21, 2024

Mesenchymal Stem Cells (MSC) Market Set to Surpass USD 9.72 - GlobeNewswire

Nov 21, 2024
pulisher
Nov 20, 2024

Diabetic Gastroparesis Pipeline 2024: Clinical Trials - openPR

Nov 20, 2024
pulisher
Nov 16, 2024

EVOK (Evoke Pharma) Total Assets : $14.15 Mil (As of Sep. 2024) - GuruFocus.com

Nov 16, 2024
pulisher
Nov 15, 2024

Diabetic Gastroparesis Treatment Market: Global Size, Share, - openPR

Nov 15, 2024
pulisher
Nov 14, 2024

Altium Capital Management LP Increases Stake in Evoke Pharma Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

CRON Experiences Significant Stock Dip Amid Market Volatility - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Aurora Cannabis (ACB) Shares Drop Amidst Financial Performance C - GuruFocus.com

Nov 13, 2024
pulisher
Nov 12, 2024

Nasal Drug Delivery Technology Market Breakthrough in Patient Care, Projected Market Growth to USD 7.8 Billion by 2031Market Research Intellect - The Malaysian Reserve

Nov 12, 2024
pulisher
Nov 12, 2024

By popular demand: SiGMA Europe launches fourth shed - GlobeNewswire Inc.

Nov 12, 2024
pulisher
Nov 12, 2024

Evoke Pharma (NASDAQ:EVOK) Coverage Initiated by Analysts at StockNews.com - Defense World

Nov 12, 2024
pulisher
Nov 10, 2024

Evoke Pharma Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 10, 2024
pulisher
Nov 08, 2024

Evoke Pharma earnings missed by $0.95, revenue fell short of estimates - Investing.com UK

Nov 08, 2024
pulisher
Nov 08, 2024

(EVOK) Trading Advice - Stock Traders Daily

Nov 08, 2024
pulisher
Nov 08, 2024

BlackLine Announces the Planned Retirement of Chief Financial Officer and Names Successor - The Manila Times

Nov 08, 2024
pulisher
Nov 08, 2024

Evoke Pharma Reports Q3 2024 Financial Results - TipRanks

Nov 08, 2024
pulisher
Nov 07, 2024

Canopy Growth (CGC) Stock Surges 5.2% Amid Industry Movement - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Nantahala Capital Management's Strategic Acquisition in Evoke Ph - GuruFocus.com

Nov 07, 2024
pulisher
Nov 06, 2024

Gastroparesis Drugs Market to Grow by USD 1.42 Billion from 2024-2028, Driven by Rising Diabetes Rates and AI-Driven Market Trend InsightsTechnavio - The Malaysian Reserve

Nov 06, 2024
pulisher
Nov 05, 2024

Ironwood Pharmaceuticals (IRWD) Sees Stock Surge Amid Positive A - GuruFocus.com

Nov 05, 2024
$11.98
price down icon 0.58%
$91.21
price up icon 2.71%
$83.72
price down icon 0.62%
drug_manufacturers_specialty_generic RDY
$15.44
price down icon 1.47%
$138.10
price up icon 0.17%
$12.28
price down icon 1.13%
Kapitalisierung:     |  Volumen (24h):